Under pathological conditions, FXR mitigates apoptosis, autophagy and ferroptosis of tubular epithelial cells, attenuates abnormal glucose and lipid metabolism and improves inflammation, oxidative stress, ER stress and fibrosis in various kidney diseases. Here, NR1H4 is linked to kidney disorder.